首页>
外国专利>
COMBINATION OF MT1 AND MT2 MELATONIN RECEPTOR AGONISTS AND A NOREPINEPHRINE/DOPAMINE REUPTAKE INHIBITOR
COMBINATION OF MT1 AND MT2 MELATONIN RECEPTOR AGONISTS AND A NOREPINEPHRINE/DOPAMINE REUPTAKE INHIBITOR
展开▼
机译:MT1和MT2褪黑素受体激动剂与去甲肾上腺素/多巴胺再摄取抑制剂的组合
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to the use of a combination of a MTl and MT2 melatonin receptor agonists and a norepinephrine/dopamine reuptake inhibitor (NDRI) for the treatment of depression and other affective disorders. It specifically relates to the use of a combination of agomelatine and bupropion for the treatment of depression and other affective disorders.
展开▼